Evogene Ltd. | CIK:0001574565 |

Filed: 3/30/2018

Entity registrant name: Evogene Ltd. (CIK: 0001574565)

Generator: GoXBRL

SEC filing page: http://www.sec.gov/Archives/edgar/data/1574565/000117891318001042/0001178913-18-001042-index.htm

XBRL Instance: http://www.sec.gov/Archives/edgar/data/1574565/000117891318001042/evgn-20171231.xml

XBRL Cloud Viewer: Click to open XBRL Cloud Viewer

EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001574565

Open this page in separate window: Click

		Year ended December 31,
		2017				2016				2015
Share-based compensation		$	2,244			$	2,943			$	4,365

Date of grant		Grantee		Options granted				Par Value (NIS)				Exercise prices (NIS)				Exercise prices ($)				Total fair value $ in thousands
March 22, 2015		President and CEO			170,000				0.02				39.62				9.78			$	663
March 22, 2015		Key officers			285,000				0.02				39.62				9.78			$	1,016
March 22, 2015		Director			2,500				0.02				38.77				9.57			$	20
		Director			2,500				0.02				40.77				10.06
July 2, 2015		Directors			12,500				0.02				39.53				10.46			$	44
November 17, 2015		Key officers			160,000				0.02				31.77				8.14			$	382
December 16, 2015		Key officer			130,000				0.02				27.73				7.15			$	298
February 29, 2016		Director			2,500				0.02				28.28				7.23			$	14
		Director			2,500				0.02				32.72				8.37
May 18, 2016		Directors			12,500				0.02				27.79				7.25			$	41
August 10, 2016		Director			10,000				0.02				26.89				7.06			$	27
September 26, 2016		Key officer			150,000				0.02				26.21				6.96			$	318
January 12, 2017		Director			2,500				0.02				21.18				5.54			$	6
April 2, 2017		Key officer			179,000				0.02				20.12				5.54			$	318
May 16, 2017		Directors			10,000				0.02				19.59				5.43			$	21
August 9, 2017		Key officers			550,000				0.02				18.71				5.20			$	705
August 10, 2017		Director			2,500				0.02				18.67				5.19			$	4
September 17, 2017		Director			2,500				0.02				17.34				4.92			$	4
October 1, 2017		Key officer			15,000				0.02				16.92				4.79			$	22

e.

Share options activity:

The following table summarizes the number of share options, the weighted average exercise price, and the changes that were made in the option plans to employees, consultants and directors:

The following table summarizes information about share options outstanding at December 31, 2017:

 

				Options outstanding
Range of exercise prices ($)				Number outstanding				Average remaining contractual life				Weighted average exercise price
2.64 – 4.95					724,437				9.36				4.81
5.19 – 6.65					1,068,000				7.71				5.60
6.81 – 7.85					1,059,270				4.72				7.33
8.09 – 9.78					951,365				6.69				9.19
10.03 – 13.70					1,142,728				5.90				12.50
17.65 – 20.39					160,500				6.36				18.75
Total					5,106,300				6.69				8.47

 

f.

The weighted average outstanding remaining contractual term of the options as of December 31, 2017 is 6.69 years (as of December 31, 2016, it was 6.17 years).

 

g.

The weighted average fair value of options granted during 2017 was $1.72 (for options granted during 2016, the fair value was $2.93).

h.

The fair value of the Company's share options granted to employees, directors and consultants for the years ended December 31, 2017, 2016 and 2015 was estimated using the binomial model with the following assumptions:

The expected volatility of the share prices reflects the assumption that the historical volatility of the share prices is reasonably indicative of expected future trends.

i.

Modifications to the conditions of the options:

On December 29, 2015 the board of directors of the Company approved for one of its key officers and several of its employees scheduled to cease their employment with the Company through January 31, 2016 an extension to the originally awarded 3 month period post-employment allowing for exercise of fully vested options to periods ranging between 6 months and 2 years from their unemployment date. The weighted average incremental fair value measured using the Black & Scholes method was approximately $0.63 per option.

On August 10, 2016 the board of directors of the Company approved for one of its key officers scheduled to cease his employment with the Company through August 31, 2016 an extension to the originally awarded 3 month period post-employment allowing for exercise of fully vested options to period of 2 years from his unemployment date. The weighted average incremental fair value measured using the binomial model was approximately $0.67 per option.

On December 28, 2016 the board of directors of the Company approved for one of its key officers scheduled to cease his employment with the Company through December 31, 2016 an extension to the originally awarded 3 month period post-employment allowing for exercise of fully vested options to period of 2 years from his unemployment date. The weighted average incremental fair value measured using the binomial model was approximately $0.05 per option.